Foundry Partners, LLC
- SEC CIK
- 0001573913
- Latest filing
- May 5, 2025
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by Foundry Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q1 2025 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −2,255−100.0% | Sold out | Holders |
| Q4 2023 | 2,255 | $217.4K | <0.1% | +2,255 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −3,188−100.0% | Sold out | Holders |
| Q2 2023 | 3,188 | $276.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,188 | $310.0K | <0.1% | −49−1.5% | Reduced | Holders |
| Q4 2022 | 3,237 | $335.0K | <0.1% | +2+0.1% | Added | Holders |
| Q3 2022 | 3,235 | $274.0K | <0.1% | +3,235 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −2,401−100.0% | Sold out | Holders |
| Q4 2021 | 2,401 | $212.0K | <0.1% | +2,401 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −2,401−100.0% | Sold out | Holders |
| Q2 2021 | 2,401 | $200.0K | <0.1% | +2,401 | New | Holders |